Abstract:Natural bisindole alkaloids such as Hyrtinadine A and Alocasin A, which are known to exhibit diverse bioactivities, provide promising chemical scaffolds for drug development. By optimizing the Masuda borylation–Suzuki coupling sequence, a library of various natural product-derived and non-natural (di)azine-bridged bisindoles was created. While unsubstituted bisindoles were devoid of antibacterial activity, 5,5′-chloro derivatives were highly active against methicillin-resistant Staphylococcus aureus (MRSA) and further Gram-positive pathogens at minimal inhibitory concentrations ranging from 0.20 to 0.78 μM. These compounds showed strong bactericidal killing effects but only moderate cytotoxicity against human cell lines. Furthermore, the two front-runner compounds 4j and 4n exhibited potent in vivo efficacy against MRSA in a mouse wound infection model. Although structurally related bisindoles were reported to specifically target pyruvate kinase in MRSA, antibacterial activity of 4j and 4n is independent of pyruvate kinase. Rather, these compounds lead to bacterial membrane permeabilization and cellular efflux of low-molecular-weight molecules.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00826?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00826</a>.MICs of compounds 4 against all tested bacteria strains (Table S1); cytotoxicity data of compounds 4j, 4n, and 4q against the human cell lines HEK293, HepG2, and CLS-54 (Table S2); SNPs present in MRSA resistant mutants (Table S3); MICs of compounds of different classes against MRSA resistant mutants and wild-type (Table S4); dose–response curve of compound 4r against MRSA (Figure S1); solubility assessment of compounds 4c, 4d, 4j, 4n, and 4r (Figure S2); absorption maxima of compounds 4c, 4d, 4j, 4n, and 4r (Figure S3); hemolytic activity of 4j and 4n on sheep red blood cells (Figure S4); stability evaluation of compound 4c (Figure S5); dose–response curves for 4d, 4n, 4q, and 4s against MRSA LAC WT and LAC Δpyk::ErmR in minimal medium M9 (Figure S6); studies describing optimization of reaction conditions (Scheme S1 and Table S5); analytical data of compounds 1a, 4a–4f, 4j, 4l–4n, 4p–4s, 4u, and 4v including 1H and 13C NMR spectra (Figures S7–S40) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Antibacterial Drug Leads Targeting Isoprenoid Biosynthesis

Undecaprenyl diphosphate synthase inhibitors: antibacterial drug leads.

Bacterial Cell Growth Inhibitors Targeting Undecaprenyl Diphosphate Synthase and Undecaprenyl Diphosphate Phosphatase

Discovery and Optimization of nTZDpa as an Antibiotic Effective Against Bacterial Persisters

Antibacterial Drug Leads: DNA and Enzyme Multitargeting.

A new class of synthetic retinoid antibiotics effective against bacterial persisters

Computer-aided drug design to generate a unique antibiotic family

Discovery and chemical optimisation of a Potent, Bi-cyclic (Bicycle ) Antimicrobial Inhibitor of PBP3

HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis

Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane

Discovery of antibacterial diketones against gram-positive bacteria

Exploration of BAY 11-7082 as a Potential Antibiotic

Small Antimicrobial Agents Based on Acylated Reduced Amide Scaffold

Targeting Bacterial Phospholipids and Their Synthesis Pathways for Antibiotic Discovery

Pharmacodynamic Functions of Synthetic Derivatives for Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis

Polyamino-Isoprenic Derivatives Block Intrinsic Resistance of P. aeruginosa to Doxycycline and Chloramphenicol In Vitro

Discovery of Unique Bis-Substituted Aromatic Amide Derivatives as Novel Highly Potent Antibiotics for Combating Methicillin-Resistant Staphylococcus aureus (MRSA)

Chemical optimization and derivatization of micrococcin p2 to target multiple bacterial infections: new antibiotics from thiopeptides

A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus

Design and synthesis of broad-spectrum antimicrobial amphiphilic peptidomimetics to combat drug-resistance

Nature-Inspired (di)Azine-Bridged Bisindole Alkaloids with Potent Antibacterial In Vitro and In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus